Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

Klinikum der Universität München, Germany

In this page

How to contact the center

Full member

HCP Center

The LMU Hospital with its two Munich sites, Campus Großhadern and Campus Innenstadt, is one of the largest university hospitals in Germany and Europe. Every year, around 500,000 patients place their trust in the expertise, care and commitment of the staff in 29 specialist clinics, thirteen institutes and seven departments as well as the 52 interdisciplinary centres. The Department of Ophthalmology is one of the largest ophthalmological centers in Germany and Europe. It has a long history of excellence in anterior and posterior segment diseases of the eye.

Contact

Klinikum der Universität München, Germany

Mathildenstraße 8
80336 Munich
Germany

Team

Dr Claudia Priglinger

Representative

Germany

See more

Pr Günther Rudolph

Substitute

Germany

See more

Clinical trials

NCT03406104 - Completed

Long-term Follow-up of ND4 LHON Subjects Treated With GS010 Ocular Gene Therapy in the RESCUE or REVERSE Phase III Clinical Trials (RESTORE)

Interventional
See the trial
voir la fiche
NCT03364153 - Active, Not recruiting

A Phase 2b Randomized, Double-masked, Controlled Trial to Establish the Safety and Efficacy of Zimura™ (Complement C5 Inhibitor) Compared to Sham in Subjects With Autosomal Recessive Stargardt Disease

Interventional
See the trial
voir la fiche

NCT04435366 - Completed

A Phase 3 Multicenter, Randomized, Double Masked, Sham- Controlled Clinical Trial to Assess the Safety and Efficacy of Intravitreal Administration of Zimura (Complement C5 Inhibitor) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Interventional
See the trial
voir la fiche
NCT05536297 - Active, Not recruiting

Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy

Interventional
See the trial
voir la fiche
NCT04276558 - Recruiting, Active

Efficacy, Safety and Pharmacokinetics of 3 Doses of REC 0/0559 Eye Drops for the Treatment of Stage 2 (Moderate) and 3 (Severe) Neurotrophic Keratitis in Adult Patients

Interventional
See the trial
voir la fiche
NCT03525600 - Completed

A Phase 3, Multi-Center, Randomized, Double-Masked, Sham-Controlled Study to Compare the Efficacy and Safety of Intravitreal Pegcetacoplan Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

Interventional
See the trial
voir la fiche
NCT04770545 - Active, Not recruiting

A Phase 3, Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Pegcetacoplan in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Interventional
See the trial
voir la fiche
DRKS00023562 - Recruiting, Active

Evaluation of the effectiveness of transcorneal electrostimulation in patients with retinitis pigmentosa - a multicenter, prospective, randomized, controlled and double-blind study on behalf of the G-BA

Interventional
See the trial
voir la fiche
NCT02686658 - Completed

A Phase 2/3 Randomized, Double-Masked, Controlled Trial to Assess the Safety and Efficacy of Intravitreous Administration of Zimura™ (Anti-C5 Aptamer) in Subjects With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

Interventional
See the trial
voir la fiche
NCT01756456 - Completed

Evaluation of safety and efficacy of r-hNGF in patients with stage 2 and 3 Neurotrophic Keratitis (REPARO).

Interventional
See the trial
voir la fiche
NCT04639635 - Recruiting, Active

Study of CNGB1 Retinitis Pigmentosa and Allied Hereditary Disorders

Observational
See the trial
voir la fiche
NCT04939571 - Recruiting, Active

European Disease Registry on Retinopathy of Prematurity (ROP)

Observational
See the trial
voir la fiche